The assay first immobilizes secreted cytokines or antibodies by allowing them to bind capture antibodies on a membrane. Labeled detection antibodies then recognize the captured molecules, producing localized signals that appear as spots. This sequence links a cell’s secretion to a spatially confined readout, enabling researchers to count responding cells rather than measuring only the total molecule in a sample.
Normalizing Spot Forming Units to a defined cell number makes responses more comparable between samples with different input sizes. The resulting value reflects the frequency of cells releasing the measured cytokine or antibody, rather than simply the amount produced by the entire culture. This supports comparisons of antigen-specific responses and immune activation across experimental groups.
SFU measurements provide a functional readout because they capture secretion by individual responding cells. They can therefore reveal antigen-specific T-cell or B-cell activity even when only a relatively small sample is available. This combination of functional information and sample efficiency helps investigators assess immune responsiveness in studies of infection, vaccination, and immunotherapy.
An ELISpot workflow places cells in contact with a membrane carrying capture antibodies, allowing secreted cytokines or antibodies to bind locally. Labeled detection antibodies are then applied to identify the captured products and produce visible spots. Investigators count those spots and report the result relative to the defined number of cells used in the assay.
Researchers can measure responses from samples exposed to a relevant antigen and compare the normalized Spot Forming Units between experimental conditions or groups. Differences in spot frequency indicate differences in the number of cells releasing the measured cytokine or antibody. This makes the assay useful for examining immune activation associated with infection, vaccination, or immunotherapy.
The measured secreted product determines the immune activity being assessed. Cytokine-focused measurements can examine antigen-specific T-cell responses, whereas antibody-focused measurements can evaluate B-cell secretion. Because the assay records these activities as localized cellular responses, SFU data can connect infection or immune intervention with changes in functional cellular immunity.